|
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Transmissible Spongiform Encephalopathies Advisory Committee
September 18, 2006
Val D. Bias
- 18 U.S.C. 208 waiver [pdf]
Ronald S. Brookmeyer, Ph.D.
- 18 U.S.C. 208 waiver [pdf]
Lynn H. Creekmore, D.V.M.
- 18 U.S.C. 208 waiver [pdf]
Michael Geschwind, M.D., Ph.D..
- 18 U.S.C. 208 waiver [pdf]
Bernardino Ghetti, M.D. (Did not attend meeting.)
- 18 U.S.C. 208 waiver [pdf]
R. Nick Hogan, Ph.D., M.D.
- 18 U.S.C. 208 waiver [pdf]
Florence Kranitz
- 18 U.S.C. 208 waiver [pdf]
James W. Lillard, Jr., Ph.D.
- 18 U.S.C. 208 waiver [pdf]
Laura K. Manuelidis, M.D.
- 18 U.S.C. 208 waiver [pdf]
James A. Mastrianni, M.D., Ph.D.
- 18 U.S.C. 208 waiver [pdf]
Mo D. Salman, D.V.M., Ph.D.
- 18 U.S.C. 208 waiver [pdf]
Glenn C. Telling, Ph.D.
- 18 U.S.C. 208 waiver [pdf]
Page updated:
October 16, 2006
|
|